XEN Gel Stent in Pediatric Glaucoma

J Glaucoma. 2020 Apr;29(4):e19-e22. doi: 10.1097/IJG.0000000000001453.

Abstract

Purpose: To report a series of 3 eyes of 3 children with congenital glaucoma receiving the XEN gel stent implant.

Patients and methods: An interventional case series is reported.

Results: Three eyes underwent implantation of the gel stent. In 2 cases, the gel implant procedure was performed after failed trabeculotomy, while in the third eye, primary gel stent implantation was performed. One eye received 2 implants. Three procedures were performed via an ab interno approach while the fourth was performed ab externo. No device-related complications were observed. In all 3 eyes, intraocular pressure was controlled without the use of topical medications through 6 to 24 months of follow-up.

Conclusions: The gel stent implant can be safely used in children with congenital glaucoma and effectively lowers intraocular pressure in these eyes. This procedure is a viable follow-up to, or replacement for, traditional angle surgery in eyes with congenital glaucoma.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Female
  • Glaucoma Drainage Implants*
  • Humans
  • Hydrophthalmos / physiopathology
  • Hydrophthalmos / surgery*
  • Infant
  • Intraocular Pressure / physiology
  • Iridectomy
  • Male
  • Minimally Invasive Surgical Procedures
  • Prosthesis Implantation
  • Stents*
  • Tonometry, Ocular
  • Treatment Outcome